New drug could make weight loss surgery safer and more effective
NCT ID NCT06721507
Summary
This study is testing whether taking the weight loss medication tirzepatide for three months before bariatric surgery improves patient outcomes. Researchers want to see if the drug reduces body-wide inflammation, which could lead to better weight loss, fewer complications, and improved health markers after surgery. The trial will compare 50 patients who take the weekly injection before their planned surgery to those who do not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OBESITY-RELATED MEDICAL CONDITIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.